- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02826239
Evaluation of Postural Effects on Multiple-breath-washout Derived Lung Function Parameters
March 23, 2020 updated by: Dr. Frederik Trinkmann, Universitätsmedizin Mannheim
The investigators aim to evaluated the effect of postural changes on novel lung function parameters derived from multiple-breath-washout.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mannheim, Germany, 68167
- Recruiting
- Universitätsmedizin Mannheim
-
Principal Investigator:
- Joachim Saur, Prof. Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with and without known pulmonary disease
Description
Inclusion Criteria:
- patients with and without known pulmonary disease
Exclusion Criteria:
- pregnancy
- inability to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Crossover
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
pulmonary healthy controls
patients without known pulmonary disease
|
measured in upright and supine position
|
|
pulmonary disease
patients with known or suspected pulmonary disease
|
measured in upright and supine position
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change of lung clearance index (LCI) as determined by multiple breath washout
Time Frame: 60 minutes
|
60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
repeatability of lung clearance index (LCI)
Time Frame: 60 minutes
|
60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
June 30, 2016
First Submitted That Met QC Criteria
July 5, 2016
First Posted (Estimate)
July 7, 2016
Study Record Updates
Last Update Posted (Actual)
March 24, 2020
Last Update Submitted That Met QC Criteria
March 23, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MBW-posture
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.